Of our 14 validated GBM-associated splicing events, eight (CAMK2A,CACNA1G, CALD1, CLTA, NF1,RTN4, TNC and TPD52L2) were previously reported (see Additional files 1 and 2). The gene discussed is TPD52L2; the disease is glioblastoma.